A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Immunogenicity of 9MW3811 in Healthy Subjects
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Idiopathic Pulmonary Fibrosis
Related studies linked through entity extraction aliases.
Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients
- Status
- COMPLETED
- Phase
- N/A
Respiratory Rate Validation Study - HiCardi+ Wearable Patch Device, Mezoo Co., Ltd.
- Status
- UNKNOWN
- Phase
- NA
Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis
- Status
- RECRUITING
- Phase
- NA
A Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease
- Status
- TERMINATED
- Phase
- PHASE2
An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical Doctors
- Status
- COMPLETED
- Phase
- N/A
Dose Reduction and Discontinuation With Anti-Fibrotic Medications
- Status
- COMPLETED
- Phase
- N/A
Faecal Microbiota Transplantation to Ameliorate Nintedanib-induced Diarrhea in Patients With Idiopathic Pulmonary Fibrosis
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001
- Status
- COMPLETED
- Phase
- PHASE1
Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809)
- Status
- COMPLETED
- Phase
- PHASE2
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- RECRUITING
- Phase
- PHASE2
Study of ARO-MMP7 Inhalation Solution in Healthy Participants and Participants With Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Atezolizumab for Idiopathic Pulmonary Fibrosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF (SAD).
- Status
- COMPLETED
- Phase
- PHASE1
To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF
- Status
- TERMINATED
- Phase
- PHASE2
To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE1